Lipella Pharmaceuticals Inc.
LIPO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2,729 | $3,737 | $2,631 | $3,197 |
| - Cash | $1,855,771 | $2,782 | $4,225 | $2,185 |
| + Debt | $264,083 | $43,178 | $24 | $48 |
| Enterprise Value | -$1,588,959 | $44,133 | -$1,570 | $1,060 |
| Revenue | $0 | $0 | $0 | $174 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | -$792 | -$993 | -$889 |
| % Margin | – | – | – | -511.7% |
| EBITDA | -$1,251,914 | -$1,356 | -$1,306 | -$1,441 |
| % Margin | – | – | – | -829.7% |
| Net Income | -$1,254,078 | -$1,327 | -$1,307 | -$1,442 |
| % Margin | – | – | – | -830.1% |
| EPS Diluted | -0.28 | -0.31 | -0.64 | -1.37 |
| % Growth | 9.7% | 51.6% | 53.3% | – |
| Operating Cash Flow | -$2,357,762 | -$1,433 | -$1,426 | -$990 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$2,357,762 | -$1,433 | -$1,426 | -$990 |